GUBBA PHARMA IN E NEWS

Read More

Zydus Life gains as Moraiya facility clears USFDA inspection

Zydus Lifesciences rose 1.70% to Rs 433.35 after the company received nil observations for pre-approval inspection conducted by US Food and Drug Administration (USFDA) at...

Continue Reading

Read More

Cipla expands diagnostics portfolio, launches point-of-care testing device

Continuing to expand its presence in the diagnostics segment, pharma major Cipla launched a point-of-care testing device for various non-communicable diseases and other medical conditions.Another...

Continue Reading

Read More

Dr. Reddy’s Laboratories launches eye drops for post-surgery care in United States

Dr. Reddy’s Laboratories Ltd. announced that it has launched Difluprednate Ophthalmic Emulsion 0.05%.This medication is used to treat swelling and pain after eye surgery. It...

Continue Reading

Read More

Biocon Chief Kiran Mazumdar Shaw leads investment in women’s health platform Gytree

Gytree.com announced its first round of fundraising, led by Biocon’s Kiran Mazumdar Shaw, Rainmatter Investments, Ajay Srinivasan former CEO of Aditya Birla Capital, Anubhuti Sharma...

Continue Reading

Read More

US FDA approves Lupin for generic drugs to treat HIV infection

Lupin, a transnational pharmaceutical company announced that it had received tentative approval from the United States Food and Drug Administration (USFDA) to market its generic...

Continue Reading

Read More

Dr Reddy’s acquires trademark rights for Pfizer breast cancer drug

Dr. Reddy’s Laboratories Ltd. announced that it has acquired the trademark rights of the breast cancer drug Primcyv from Pfizer ProductsIndia Pvt Ltd for use...

Continue Reading

Read More

All about iNcovacc, the intranasal Covid-19 vaccine of Bharat Biotech

The world’s first intranasal vaccine, christened as iNcovacc, is based on a delivery vehicle, a virus, that causes the common cold (adenovirus vector). The spike...

Continue Reading

Read More

Cipla to invest 15 million euros in Germany’s Ethris to expand respiratory portfolio

Pharmaceutical major Cipla NSE 0.46 % announced that its wholly-owned UK subsidiary Cipla (EU) Limited has signed definitive agreements to invest 15 million euros in...

Continue Reading

Read More

Sun Pharma’s proposal to amend CT protocol for pimavanserin gets CDSCO Panel nod

Approving Sun Pharma’s proposal to amend the existing clinical trial protocol for the atypical antipsychotic Pimavanserin Capsules, the Subject Expert Committee (SEC) functional under the...

Continue Reading